Detalhe da pesquisa
1.
Is the Toxicity of Salvage Prostatectomy Related to the Primary Prostate Cancer Therapy Received?
J Urol
; 205(3): 791-799, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33021441
2.
The application of theranostics in different stages of prostate cancer.
Future Oncol
; 17(27): 3637-3644, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34227404
4.
Novel agents for metastatic hormone-sensitive prostate cancer - a practice guide for urologists.
BJU Int
; 125(3): 342-345, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31660679
5.
Administering [177Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm, Phase 1/2 Study.
Eur Urol
; 85(3): 217-226, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37891072
6.
A Novel Risk Calculator Incorporating Clinical Parameters, Multiparametric Magnetic Resonance Imaging, and Prostate-Specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Risk Stratification Before Transperineal Prostate Biopsy.
Eur Urol Open Sci
; 53: 90-97, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37441340
7.
The PRIMARY Score: Using Intraprostatic 68Ga-PSMA PET/CT Patterns to Optimize Prostate Cancer Diagnosis.
J Nucl Med
; 63(11): 1644-1650, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35301240
8.
Clinical Trial Protocol for LuTectomy: A Single-arm Study of the Dosimetry, Safety, and Potential Benefit of 177Lu-PSMA-617 Prior to Prostatectomy.
Eur Urol Focus
; 7(2): 234-237, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33172774
9.
The Additive Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography Computed Tomography to Multiparametric Magnetic Resonance Imaging Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre Study.
Eur Urol
; 80(6): 682-689, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34465492
10.
Indirect Comparisons of Efficacy between Combination Approaches in Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Network Meta-analysis.
Eur Urol
; 77(3): 365-372, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31679970
11.
PSMA-PET to detect prostate cancer recurrence after radiotherapy.
Nat Rev Urol
; 20(1): 5-6, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36316467
12.
The Role of Local Therapy for Oligometastatic Prostate Cancer: Should We Expect a Cure?
Urol Clin North Am
; 44(4): 623-633, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29107278
13.
Re: PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients with Metastatic Castration-resistant Prostate Cancer.
Eur Urol
; 77(1): 130-131, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31352976
14.
Less, not More, Antibiotics Please.
Eur Urol Focus
; 6(1): 102-103, 2020 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30177401
15.
Are we ready to adopt the European Association of Urology recommendations on multiparametric magnetic resonance imaging in the early detection of prostate cancer?
Investig Clin Urol
; 60(4): 225-226, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31294130
16.
Re: Darolutamide in Nonmetastatic Castration-Resistant Prostate Cancer.
Eur Urol
; 76(4): 536-537, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31101535
17.
Balancing the benefits and harms of radiotherapy post-radical prostatectomy.
Transl Androl Urol
; 7(Suppl 1): S128-S131, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29644180